nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Thrombocytopenic purpura—Thiotepa—sarcoma	0.0307	0.0307	CcSEcCtD
Lincomycin—Azotaemia—Vincristine—sarcoma	0.024	0.024	CcSEcCtD
Lincomycin—Induration—Etoposide—sarcoma	0.0232	0.0232	CcSEcCtD
Lincomycin—Local reaction—Mitoxantrone—sarcoma	0.0225	0.0225	CcSEcCtD
Lincomycin—Anorectal discomfort—Etoposide—sarcoma	0.0189	0.0189	CcSEcCtD
Lincomycin—Abdominal cramps—Vincristine—sarcoma	0.0189	0.0189	CcSEcCtD
Lincomycin—Oliguria—Thiotepa—sarcoma	0.0156	0.0156	CcSEcCtD
Lincomycin—Proteinuria—Mitoxantrone—sarcoma	0.0142	0.0142	CcSEcCtD
Lincomycin—Protein urine present—Mitoxantrone—sarcoma	0.014	0.014	CcSEcCtD
Lincomycin—Colitis—Thiotepa—sarcoma	0.0138	0.0138	CcSEcCtD
Lincomycin—Aplastic anaemia—Dactinomycin—sarcoma	0.0134	0.0134	CcSEcCtD
Lincomycin—Oesophagitis—Thiotepa—sarcoma	0.0132	0.0132	CcSEcCtD
Lincomycin—Oesophagitis—Dactinomycin—sarcoma	0.0131	0.0131	CcSEcCtD
Lincomycin—Phlebitis—Dactinomycin—sarcoma	0.0121	0.0121	CcSEcCtD
Lincomycin—Anorectal discomfort—Epirubicin—sarcoma	0.0106	0.0106	CcSEcCtD
Lincomycin—Phlebitis—Mitoxantrone—sarcoma	0.0105	0.0105	CcSEcCtD
Lincomycin—Local reaction—Epirubicin—sarcoma	0.0105	0.0105	CcSEcCtD
Lincomycin—Vesiculobullous rash—Epirubicin—sarcoma	0.0104	0.0104	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—sarcoma	0.00982	0.00982	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—sarcoma	0.0097	0.0097	CcSEcCtD
Lincomycin—Liver function test abnormal—Dactinomycin—sarcoma	0.00959	0.00959	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—sarcoma	0.00958	0.00958	CcSEcCtD
Lincomycin—Oesophagitis—Etoposide—sarcoma	0.00946	0.00946	CcSEcCtD
Lincomycin—Phlebitis—Etoposide—sarcoma	0.00872	0.00872	CcSEcCtD
Lincomycin—Pancytopenia—Thiotepa—sarcoma	0.00859	0.00859	CcSEcCtD
Lincomycin—Pancytopenia—Dactinomycin—sarcoma	0.00852	0.00852	CcSEcCtD
Lincomycin—Neutropenia—Dactinomycin—sarcoma	0.00839	0.00839	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00793	0.00793	CcSEcCtD
Lincomycin—Stomatitis—Thiotepa—sarcoma	0.00786	0.00786	CcSEcCtD
Lincomycin—Jaundice—Thiotepa—sarcoma	0.00786	0.00786	CcSEcCtD
Lincomycin—Stomatitis—Dactinomycin—sarcoma	0.0078	0.0078	CcSEcCtD
Lincomycin—Pancytopenia—Vincristine—sarcoma	0.00762	0.00762	CcSEcCtD
Lincomycin—Agranulocytosis—Thiotepa—sarcoma	0.00752	0.00752	CcSEcCtD
Lincomycin—Neutropenia—Vincristine—sarcoma	0.0075	0.0075	CcSEcCtD
Lincomycin—Agranulocytosis—Dactinomycin—sarcoma	0.00747	0.00747	CcSEcCtD
Lincomycin—Pancytopenia—Mitoxantrone—sarcoma	0.00742	0.00742	CcSEcCtD
Lincomycin—Abscess—Epirubicin—sarcoma	0.00734	0.00734	CcSEcCtD
Lincomycin—Neutropenia—Mitoxantrone—sarcoma	0.0073	0.0073	CcSEcCtD
Lincomycin—Rash pustular—Epirubicin—sarcoma	0.00728	0.00728	CcSEcCtD
Lincomycin—Stomatitis—Vincristine—sarcoma	0.00697	0.00697	CcSEcCtD
Lincomycin—Erythema multiforme—Dactinomycin—sarcoma	0.00679	0.00679	CcSEcCtD
Lincomycin—Stomatitis—Mitoxantrone—sarcoma	0.00679	0.00679	CcSEcCtD
Lincomycin—Jaundice—Mitoxantrone—sarcoma	0.00679	0.00679	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—sarcoma	0.00679	0.00679	CcSEcCtD
Lincomycin—Tinnitus—Thiotepa—sarcoma	0.00675	0.00675	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—sarcoma	0.00673	0.00673	CcSEcCtD
Lincomycin—Agranulocytosis—Mitoxantrone—sarcoma	0.0065	0.0065	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—sarcoma	0.0063	0.0063	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—sarcoma	0.0063	0.0063	CcSEcCtD
Lincomycin—Pancytopenia—Etoposide—sarcoma	0.00617	0.00617	CcSEcCtD
Lincomycin—Neutropenia—Etoposide—sarcoma	0.00607	0.00607	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—sarcoma	0.00583	0.00583	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—sarcoma	0.00583	0.00583	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—sarcoma	0.0058	0.0058	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00574	0.00574	CcSEcCtD
Lincomycin—Jaundice—Etoposide—sarcoma	0.00565	0.00565	CcSEcCtD
Lincomycin—Stomatitis—Etoposide—sarcoma	0.00565	0.00565	CcSEcCtD
Lincomycin—Leukopenia—Thiotepa—sarcoma	0.00564	0.00564	CcSEcCtD
Lincomycin—Leukopenia—Dactinomycin—sarcoma	0.0056	0.0056	CcSEcCtD
Lincomycin—Colitis—Epirubicin—sarcoma	0.00557	0.00557	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—sarcoma	0.00548	0.00548	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—sarcoma	0.00545	0.00545	CcSEcCtD
Lincomycin—Agranulocytosis—Etoposide—sarcoma	0.0054	0.0054	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—sarcoma	0.00537	0.00537	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—sarcoma	0.0053	0.0053	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—sarcoma	0.00516	0.00516	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—sarcoma	0.00507	0.00507	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—sarcoma	0.00504	0.00504	CcSEcCtD
Lincomycin—Vertigo—Vincristine—sarcoma	0.00502	0.00502	CcSEcCtD
Lincomycin—Leukopenia—Vincristine—sarcoma	0.005	0.005	CcSEcCtD
Lincomycin—Erythema multiforme—Etoposide—sarcoma	0.00492	0.00492	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—sarcoma	0.00491	0.00491	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—sarcoma	0.00489	0.00489	CcSEcCtD
Lincomycin—Leukopenia—Mitoxantrone—sarcoma	0.00487	0.00487	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—sarcoma	0.00487	0.00487	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—sarcoma	0.00482	0.00482	CcSEcCtD
Lincomycin—Anaphylactic shock—Vincristine—sarcoma	0.00456	0.00456	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—sarcoma	0.00452	0.00452	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—sarcoma	0.00446	0.00446	CcSEcCtD
Lincomycin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00444	0.00444	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—sarcoma	0.00441	0.00441	CcSEcCtD
Lincomycin—Pain—Thiotepa—sarcoma	0.0044	0.0044	CcSEcCtD
Lincomycin—Shock—Mitoxantrone—sarcoma	0.00437	0.00437	CcSEcCtD
Lincomycin—Pain—Dactinomycin—sarcoma	0.00436	0.00436	CcSEcCtD
Lincomycin—Hypotension—Vincristine—sarcoma	0.00426	0.00426	CcSEcCtD
Lincomycin—Hypotension—Mitoxantrone—sarcoma	0.00415	0.00415	CcSEcCtD
Lincomycin—Urticaria—Thiotepa—sarcoma	0.00409	0.00409	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—sarcoma	0.00408	0.00408	CcSEcCtD
Lincomycin—Vertigo—Etoposide—sarcoma	0.00407	0.00407	CcSEcCtD
Lincomycin—Body temperature increased—Thiotepa—sarcoma	0.00407	0.00407	CcSEcCtD
Lincomycin—Abdominal pain—Thiotepa—sarcoma	0.00407	0.00407	CcSEcCtD
Lincomycin—Leukopenia—Etoposide—sarcoma	0.00405	0.00405	CcSEcCtD
Lincomycin—Abdominal pain—Dactinomycin—sarcoma	0.00403	0.00403	CcSEcCtD
Lincomycin—Body temperature increased—Dactinomycin—sarcoma	0.00403	0.00403	CcSEcCtD
Lincomycin—Pain—Vincristine—sarcoma	0.0039	0.0039	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—sarcoma	0.00389	0.00389	CcSEcCtD
Lincomycin—Pain—Mitoxantrone—sarcoma	0.0038	0.0038	CcSEcCtD
Lincomycin—Hypersensitivity—Thiotepa—sarcoma	0.00379	0.00379	CcSEcCtD
Lincomycin—Hypersensitivity—Dactinomycin—sarcoma	0.00376	0.00376	CcSEcCtD
Lincomycin—Anaphylactic shock—Etoposide—sarcoma	0.00369	0.00369	CcSEcCtD
Lincomycin—Pruritus—Thiotepa—sarcoma	0.00364	0.00364	CcSEcCtD
Lincomycin—Abdominal pain—Vincristine—sarcoma	0.0036	0.0036	CcSEcCtD
Lincomycin—Body temperature increased—Vincristine—sarcoma	0.0036	0.0036	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—sarcoma	0.0036	0.0036	CcSEcCtD
Lincomycin—Urticaria—Mitoxantrone—sarcoma	0.00353	0.00353	CcSEcCtD
Lincomycin—Diarrhoea—Thiotepa—sarcoma	0.00352	0.00352	CcSEcCtD
Lincomycin—Abdominal pain—Mitoxantrone—sarcoma	0.00351	0.00351	CcSEcCtD
Lincomycin—Body temperature increased—Mitoxantrone—sarcoma	0.00351	0.00351	CcSEcCtD
Lincomycin—Diarrhoea—Dactinomycin—sarcoma	0.00349	0.00349	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—sarcoma	0.00346	0.00346	CcSEcCtD
Lincomycin—Hypotension—Etoposide—sarcoma	0.00345	0.00345	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Lincomycin—Hypersensitivity—Vincristine—sarcoma	0.00336	0.00336	CcSEcCtD
Lincomycin—Hypersensitivity—Mitoxantrone—sarcoma	0.00327	0.00327	CcSEcCtD
Lincomycin—Vomiting—Thiotepa—sarcoma	0.00327	0.00327	CcSEcCtD
Lincomycin—Vomiting—Dactinomycin—sarcoma	0.00325	0.00325	CcSEcCtD
Lincomycin—Rash—Thiotepa—sarcoma	0.00324	0.00324	CcSEcCtD
Lincomycin—Dermatitis—Thiotepa—sarcoma	0.00324	0.00324	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Lincomycin—Rash—Dactinomycin—sarcoma	0.00322	0.00322	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—sarcoma	0.0032	0.0032	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Lincomycin—Pain—Etoposide—sarcoma	0.00316	0.00316	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Lincomycin—Diarrhoea—Vincristine—sarcoma	0.00312	0.00312	CcSEcCtD
Lincomycin—Nausea—Thiotepa—sarcoma	0.00305	0.00305	CcSEcCtD
Lincomycin—Diarrhoea—Mitoxantrone—sarcoma	0.00304	0.00304	CcSEcCtD
Lincomycin—Nausea—Dactinomycin—sarcoma	0.00303	0.00303	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—sarcoma	0.00303	0.00303	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Lincomycin—Urticaria—Etoposide—sarcoma	0.00293	0.00293	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Lincomycin—Body temperature increased—Etoposide—sarcoma	0.00292	0.00292	CcSEcCtD
Lincomycin—Abdominal pain—Etoposide—sarcoma	0.00292	0.00292	CcSEcCtD
Lincomycin—Vomiting—Vincristine—sarcoma	0.0029	0.0029	CcSEcCtD
Lincomycin—Rash—Vincristine—sarcoma	0.00288	0.00288	CcSEcCtD
Lincomycin—Dermatitis—Vincristine—sarcoma	0.00287	0.00287	CcSEcCtD
Lincomycin—Vomiting—Mitoxantrone—sarcoma	0.00282	0.00282	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Lincomycin—Rash—Mitoxantrone—sarcoma	0.0028	0.0028	CcSEcCtD
Lincomycin—Dermatitis—Mitoxantrone—sarcoma	0.0028	0.0028	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Lincomycin—Hypersensitivity—Etoposide—sarcoma	0.00272	0.00272	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—sarcoma	0.00272	0.00272	CcSEcCtD
Lincomycin—Nausea—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Lincomycin—Nausea—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Lincomycin—Pruritus—Etoposide—sarcoma	0.00261	0.00261	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Lincomycin—Diarrhoea—Etoposide—sarcoma	0.00253	0.00253	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Lincomycin—Vomiting—Etoposide—sarcoma	0.00235	0.00235	CcSEcCtD
Lincomycin—Rash—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Lincomycin—Dermatitis—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Lincomycin—Nausea—Etoposide—sarcoma	0.00219	0.00219	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Lincomycin—Shock—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Lincomycin—Shock—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Lincomycin—Pain—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Lincomycin—Pain—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Lincomycin—Rash—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Lincomycin—Nausea—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Lincomycin—Rash—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
